We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

This was the stock's second consecutive day of losses.

Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 20 years ago, it would be worth $134,486.89 today based ...

REGN's average consensus price target is 38.95% higher at $973.13, and its highest analyst price target sits at $1,300. It ...

Jones Financial Companies Lllp increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) ...

Secondly, to support the stock price, Regeneron management announced the authorization of an additional $3 billion, which will go towards a share buyback program. The New York-based company ...

NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...

Sanford C. Bernstein lowered their price objective on shares of Regeneron Pharmaceuticals from $1,110.00 to $1,070.00 and set an “outperform” rating on the stock in a research report on ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals Inc ... we used the Finviz stock screener to look for stocks that analysts believe will gain more than 30% in ...

On this news, the price of Regeneron stock fell, according to the complaint. Then, on October 31, 2024, the Regeneron class action lawsuit further alleges that Regeneron announced its third ...

Given the accelerating sales growth of LIBTAYO and stabilization in the EYLEA franchise, investors bid up the price of Regeneron's stock by +4.5% on Tuesday. The company's robust performance makes ...

Its stock closed down 18.9% for 2024 ... $614.28 and $575.49. REGN’s average consensus price target is 38.95% higher at $973.13, and its highest analyst price target sits at $1,300.